This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                         What's this?

 Previous Article  |  Next Article 

Haemophilus influenzae Type B Conjugate Vaccines: Recommendations for the Immunization of Infants and Children at 2 Months of Age and Older, an Update

This statement is provided in response to the December 1990 US Food and Drug Administration (FDA) approval of labelling for a second Haemophilus influenzae type b conjugate vaccine, PRP-OMP (Table 1) for administration to infants as young as 2 months of age. The following recommendatios supercede previous American Academy of Pediatrics guidelines for the use of H influenzae type b conjugate vaccines.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?